Share Price:

APNASPENAspen Pharmacare Hldgs2324952 (0.22%)

Aspen is in a closed period from 1st July 2024 until the publication of the FY2024 results on the JSE SENS platform to be released on the 3rd September 2024.

Aspen announces R500 million investment at 4th SAIC

President Cyril Ramaphosa thanks Stavros Nicolaou for Aspen's R500 million pledge

Johannesburg, South Africa – Aspen Pharmacare, a global specialty and branded pharmaceutical company and Africa’s largest pharmaceutical company, has announced a further investment of some R500 million to its flagship pharmaceutical manufacturing site in Gqeberha. The announcement comes in the wake of more than R8 billion which Aspen has already invested in this world class… Continue reading Aspen announces R500 million investment at 4th SAIC

Aspen donates life-saving medicines for 62000 surgeries in Ukraine

Aspen has donated life saving medicines valued at R11 million to facilitate 62 000 surgeries in Ukraine

Johannesburg, South Africa – Aspen Pharmacare, Africa’s largest pharmaceutical company, has extended its support to Ukraine with donations of life-saving medicines required for urgent surgical intervention. This action further demonstrates Aspen’s ongoing commitment to saving lives and improving the quality of life of patients irrespective of their location or circumstances. Stavros Nicolaou Aspen Senior Executive… Continue reading Aspen donates life-saving medicines for 62000 surgeries in Ukraine

Aspen helps evacuate SA students stranded in the Ukraine

Aspen partnered with the the South African Department of International Relations and Cooperation to repatriate students from the Ukraine

Aspen partners with South African Government to evacuate South African Student’s from the Ukraine conflict Johannesburg, South Africa – Aspen Pharmacare, Africa’s largest pharmaceutical company, has partnered with the South African Department of International Relations and Cooperation (“DIRCO”) to assist in the emergency evacuation of South African students who have been studying at various Universities… Continue reading Aspen helps evacuate SA students stranded in the Ukraine

Aspen concludes agreement to manufacture and make available an Aspen-branded COVID-19 vaccine (Aspenovax) throughout Africa

Stephen Saad, Aspen Group Chief Executive

“With the conclusion of this agreement, our vision for Africa’s own vaccine has become a reality,” said Stephen Saad, Aspen Group Chief Executive.

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.